ADUS Quote, Financials, Valuation and Earnings

Quest Diagnostics has a net margin of 6.96% compared to Addus HomeCare's net margin of 9.08%. Addus HomeCare's return on equity of 9.24% beat Quest Diagnostics's return on equity of 12.68%.

Addus HomeCare has a consensus price target of $137.82, signalling upside risk potential of 7.47%. On the other hand Quest Diagnostics has an analysts' consensus of $169.96 which suggests that it could grow by 11.35%. Given that Quest Diagnostics has higher upside potential than Addus HomeCare, analysts believe Quest Diagnostics is more attractive than Addus HomeCare.

Addus HomeCare has a beta of 1.015, which suggesting that the stock is 1.53% more volatile than S&P 500. In comparison Quest Diagnostics has a beta of 0.893, suggesting its less volatile than the S&P 500 by 10.74%.

Addus HomeCare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Quest Diagnostics offers a yield of 1.94% to investors and pays a quarterly dividend of $0.75 per share. Addus HomeCare pays -- of its earnings as a dividend. Quest Diagnostics pays out 36.77% of its earnings as a dividend. Quest Diagnostics's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Addus HomeCare quarterly revenues are $289.8M, which are smaller than Quest Diagnostics quarterly revenues of $2.5B. Addus HomeCare's net income of $20.2M is lower than Quest Diagnostics's net income of $226M. Notably, Addus HomeCare's price-to-earnings ratio is 29.35x while Quest Diagnostics's PE ratio is 20.51x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Addus HomeCare is 1.91x versus 1.80x for Quest Diagnostics. Usually stocks with elevated PS ratios are considered overvalued.

Option Care Health has a net margin of 6.96% compared to Addus HomeCare's net margin of 4.21%. Addus HomeCare's return on equity of 9.24% beat Option Care Health's return on equity of 14.65%.

Addus HomeCare has a consensus price target of $137.82, signalling upside risk potential of 7.47%. On the other hand Option Care Health has an analysts' consensus of -- which suggests that it could grow by 31.78%. Given that Option Care Health has higher upside potential than Addus HomeCare, analysts believe Option Care Health is more attractive than Addus HomeCare.

Addus HomeCare has a beta of 1.015, which suggesting that the stock is 1.53% more volatile than S&P 500. In comparison Option Care Health has a beta of 1.332, suggesting its more volatile than the S&P 500 by 33.16%.

Addus HomeCare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Option Care Health offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Addus HomeCare pays -- of its earnings as a dividend. Option Care Health pays out -- of its earnings as a dividend.

Addus HomeCare quarterly revenues are $289.8M, which are smaller than Option Care Health quarterly revenues of $1.3B. Addus HomeCare's net income of $20.2M is lower than Option Care Health's net income of $53.9M. Notably, Addus HomeCare's price-to-earnings ratio is 29.35x while Option Care Health's PE ratio is 19.20x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Addus HomeCare is 1.91x versus 0.84x for Option Care Health. Usually stocks with elevated PS ratios are considered overvalued.

OptimizeRx has a net margin of 6.96% compared to Addus HomeCare's net margin of -42.82%. Addus HomeCare's return on equity of 9.24% beat OptimizeRx's return on equity of -20.12%.

Addus HomeCare has a consensus price target of $137.82, signalling upside risk potential of 7.47%. On the other hand OptimizeRx has an analysts' consensus of $9.79 which suggests that it could grow by 92.25%. Given that OptimizeRx has higher upside potential than Addus HomeCare, analysts believe OptimizeRx is more attractive than Addus HomeCare.

Addus HomeCare has a beta of 1.015, which suggesting that the stock is 1.53% more volatile than S&P 500. In comparison OptimizeRx has a beta of 1.341, suggesting its more volatile than the S&P 500 by 34.097%.

Addus HomeCare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. OptimizeRx offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Addus HomeCare pays -- of its earnings as a dividend. OptimizeRx pays out -- of its earnings as a dividend.

Addus HomeCare quarterly revenues are $289.8M, which are larger than OptimizeRx quarterly revenues of $21.3M. Addus HomeCare's net income of $20.2M is higher than OptimizeRx's net income of -$9.1M. Notably, Addus HomeCare's price-to-earnings ratio is 29.35x while OptimizeRx's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Addus HomeCare is 1.91x versus 1.05x for OptimizeRx. Usually stocks with elevated PS ratios are considered overvalued.

Regional Health Properties has a net margin of 6.96% compared to Addus HomeCare's net margin of -23.24%. Addus HomeCare's return on equity of 9.24% beat Regional Health Properties's return on equity of -489.72%.

Addus HomeCare has a consensus price target of $137.82, signalling upside risk potential of 7.47%. On the other hand Regional Health Properties has an analysts' consensus of -- which suggests that it could grow by 319.36%. Given that Regional Health Properties has higher upside potential than Addus HomeCare, analysts believe Regional Health Properties is more attractive than Addus HomeCare.

Addus HomeCare has a beta of 1.015, which suggesting that the stock is 1.53% more volatile than S&P 500. In comparison Regional Health Properties has a beta of 0.916, suggesting its less volatile than the S&P 500 by 8.446%.

Addus HomeCare has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Regional Health Properties offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Addus HomeCare pays -- of its earnings as a dividend. Regional Health Properties pays out -- of its earnings as a dividend.

Addus HomeCare quarterly revenues are $289.8M, which are larger than Regional Health Properties quarterly revenues of $4.2M. Addus HomeCare's net income of $20.2M is higher than Regional Health Properties's net income of -$982K. Notably, Addus HomeCare's price-to-earnings ratio is 29.35x while Regional Health Properties's PE ratio is 0.13x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Addus HomeCare is 1.91x versus 0.17x for Regional Health Properties. Usually stocks with elevated PS ratios are considered overvalued.